Division of Cardiovascular Medicine Archives
COVID-19’s lingering impact on health
Apr. 6, 2023—A decline in cardiovascular fitness — measured by activity trackers in the All of Us research program — persisted among some groups even after COVID-related restrictions were relaxed, exacerbating health disparities.
Cell-free hemoglobin in pulmonary hypertension
Mar. 6, 2023—Cell-free hemoglobin generated by the lungs may be a therapeutic target for treating pulmonary arterial hypertension, Vanderbilt researchers found.
A new view of a cholesterol carrier
Feb. 7, 2023—Vanderbilt researchers developed a novel method to measure small RNAs carried by HDL and demonstrated that these molecules circulate in greater concentrations than previously believed and are likely to contribute to communication between immune cells.
Study finds heart failure risk higher in rural areas
Jan. 25, 2023—A study co-led by Vanderbilt researchers found heart failure risk is 19% higher for adults living in rural areas of the U.S., as compared to urban areas, and 34% higher for Black men living in rural areas.
Study explores CVD risk for people with HIV
Nov. 10, 2022—A Vanderbilt study found that among people with HIV infection, three types of CD4+ T helper cells are associated with incident cardiovascular disease (CVD) that are not explained by CVD risk.
Study shows CMS reimbursement not associated with wider EPD use
Sep. 29, 2022—Vanderbilt research shows that higher reimbursement from the Centers for Medicare & Medicaid Services was not associated with wider use of an embolic protection device during transcatheter aortic valve replacement procedures.
Study suggests new mechanism for lipid transporter
Sep. 15, 2022—A new model suggests that a protein involved in the generation of high-density lipoprotein (HDL) works differently than previously thought.
Lindley named to direct new multidisciplinary Women’s Heart Center
Aug. 17, 2022—Kathryn Lindley, MD, has joined the Vanderbilt Heart and Vascular Institute as director of the new Women’s Heart Center.
Genotype-specific blood counts
Aug. 11, 2022—Vanderbilt researchers report genotype-specific reference ranges to improve interpretation of laboratory blood results in African Americans with a common gene variant that lowers white blood cell counts.
Peptides promote AFib arrhythmia
Apr. 11, 2022—Peptide oligomers have detrimental metabolic effects and cause pro-arrhythmic electrophysiological changes in heart atria, suggesting they may contribute to atrial fibrillation.
Department of Medicine announces $1 million endowment to support diversity, inclusion efforts
Mar. 14, 2022—Vanderbilt University Medical Center’s Department of Medicine has announced a $1 million endowment dedicated to the department’s efforts in diversity and inclusion.
American College of Cardiology honors Vanderbilt’s Dixon, Thomas
Mar. 10, 2022—Two fellows in Vanderbilt's Division of Cardiovascular Medicine have received awards from the American College of Cardiology and the Association of Black Cardiologists.
